Positive Data for Cannabis Chewing Gum to be Used in Upcoming IBS Trial
|Positive Data for Cannabis Chewing Gum to be Used in Upcoming IBS Trial||Darrell Miller||01/19/17|
January 19, 2017 12:59 PM
Author: Darrell Miller (firstname.lastname@example.org)
Subject: Positive Data for Cannabis Chewing Gum to be Used in Upcoming IBS Trial
There is a new cannabis chewing gum that just received positive pharmacokinetic data results. The gum is called CanChew Plus, is non habit forming, and is apparently available in all 50 states. It will come in a 30mg dose, which has been proven to be the most effective dosage amount.
- CanChew Plus is a non-habit forming, hemp-derived CBD functional chewing gum that is available in all 50 states.
- The single-dose study for 10 mg and 30 mg of CBD determined the concentration of CBD in the blood after chewing CanChew Plus Gum for 30 minutes in healthy participants.
- “These results show that excellent bioavailability for CBD may be achieved via our proprietary chewing gum delivery system, so that patients suffering from IBS may have symptomatic relief using an easy-to-use solution."
"Currently, AXIM is gearing up for a clinical trial to prove the efficacy of CBD for the treatment of irritable bowel syndrome."